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Abstract
Silk-based biomaterials in combination with extracellular matrix (ECM) coatings were assessed as templates for cell-seeded
bladder tissue engineering approaches. Two structurally diverse groups of silk scaffolds were produced by a gel spinning
process and consisted of either smooth, compact multi-laminates (Group 1) or rough, porous lamellar-like sheets (Group 2).
Scaffolds alone or coated with collagen types I or IV or fibronectin were assessed independently for their ability to support
attachment, proliferation, and differentiation of primary cell lines including human bladder smooth muscle cells (SMC) and
urothelial cells as well as pluripotent cell populations, such as murine embryonic stem cells (ESC) and induced pluripotent
stem (iPS) cells. AlamarBlue evaluations revealed that fibronectin-coated Group 2 scaffolds promoted the highest degree of
primary SMC and urothelial cell attachment in comparison to uncoated Group 2 controls and all Group 1 scaffold variants.
Real time RT-PCR and immunohistochemical (IHC) analyses demonstrated that both fibronectin-coated silk groups were
permissive for SMC contractile differentiation as determined by significant upregulation of a-actin and SM22a mRNA and
protein expression levels following TGFb1 stimulation. Prominent expression of epithelial differentiation markers,
cytokeratins, was observed in urothelial cells cultured on both control and fibronectin-coated groups following IHC analysis.
Evaluation of silk matrices for ESC and iPS cell attachment by alamarBlue showed that fibronectin-coated Group 2 scaffolds
promoted the highest levels in comparison to all other scaffold formulations. In addition, real time RT-PCR and IHC analyses
showed that fibronectin-coated Group 2 scaffolds facilitated ESC and iPS cell differentiation toward both urothelial and
smooth muscle lineages in response to all trans retinoic acid as assessed by induction of uroplakin and contractile gene and
protein expression. These results demonstrate that silk scaffolds support primary and pluripotent cell responses pertinent to
bladder tissue engineering and that scaffold morphology and fibronectin coatings influence these processes.
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Introduction
Surgical management of a variety of bladder disorders including
neurogenic bladder, posterior urethral valves, and bladder
exstrophy frequently requires augmentation cystoplasty in order
to prevent renal damage and incontinence from increased urinary
storage and voiding pressures [1]. Currently, gastrointestinal
segments represent the primary option for bladder reconstructive
procedures despite numerous complications including chronic
urinary tract infection, stone formation, graft rupture, as well as
secondary malignancies [2]. Previous studies in bladder tissue
engineering have investigated both natural and synthetic scaffolds
either alone or seeded with autologous bladder cell populations as
alternative strategies for defect repair or neobladder reconstruction
[3]. Conventional scaffolds such as acellular bladder matrix
(ABM), poly-glycolic acid (PGA), and small intestinal submucosa
(SIS) have been reported to support bladder tissue regeneration in
various animal models [4–6] and in some cases short-term clinical
trials [7,8]. However these matrices are frequently associated with
various deleterious side effects including implant contracture,
calcification, and fibrosis and therefore may be restricted in their
long-term clinical potential [9–11].
Biomaterials derived from Bombyx mori silk fibroin represent an
emerging platform for bladder tissue engineering due to their
mechanical robustness [12], processing plasticity [13], and
biodegradability [14]. In particular, the process of gel spinning
allows for the formation of 3-D biomaterials with selective
structural and mechanical properties through controlled variations
in winding and post-winding fabrication parameters [15–17]. Our
previous results have shown that acellular silk scaffolds were
capable of supporting murine bladder augmentation wherein they
displayed significant advantages in comparison to PGA and SIS
matrices including superior tissue regeneration, reduced inflam-
matory reactions, and improved functional performance [16]. In
PLOS ONE | www.plosone.org 1 February 2013 | Volume 8 | Issue 2 | e56237addition, we reported that manipulation of silk matrix properties
can influence the extent of in vivo scaffold degradation and host
tissue integration [17]. These studies reveal that the silk gel
spinning process represents a tunable system for understanding the
ability of specific biomaterial characteristics to support reconsti-
tution of lower urinary tract defects.
Large animal studies of bladder augmentation have highlighted
several limitations associated with the use of acellular scaffolds for
defect consolidation [18,19]. These matrices rely on the capacity
of host cell populations to migrate, expand, and differentiate
throughout the wound site in order to promote de novo tissue
formation and restoration of organ function. In a non-diseased
porcine model, Brown and colleagues observed that host tissue
integration was restricted to the periphery of SIS grafts (46 cm
2),
while central regions of the implant failed to support organized
smooth muscle bundles or urothelial maturation [18]. These
results suggest that acellular biomaterials may be hampered in
their ability to heal defects of clinically relevant size due to a lack of
host cell infiltration. This issue can be further compounded by
disease pathology, wherein aberrations in host cell functionality
may restrict their ability to populate and repair defect sites.
Indeed, a study by the Kaefer group demonstrated that while
augmentation of healthy porcine bladders with an acellular dermal
biomatrix resulted in functional regeneration of small scale defects,
similar experiments in an obstructed bladder model failed to show
favorable results [19].
Cell seeding of biomaterials prior to implantation has been
demonstrated as a viable approach for enhancing the repair
efficacy of acellular scaffolds. Atala and colleagues reported that
PGA matrices seeded with primary smooth muscle cells (SMC)
and urothelial cells improved the extent of bladder tissue
regeneration over non-seeded controls [5]. The feasibility of tissue
engineered constructs seeded with autologous primary cells has
also been validated in short term clinical trials of bladder
augmentation [7]. Unfortunately, tissue-specific primary cells
may be limited for therapeutic use in some patients due to a lack
of availability or diseased phenotype [20,21]. To circumvent these
issues, researchers have investigated the utility of multi-potent
adult stem cells for bladder reconstruction including both bone
marrow and adipose-derived mesenchymal stem cells (MSC)
[22,23]. These reports have shown that scaffold-seeded MSC
populations can contribute to bladder smooth muscle regeneration
in vivo; however their capacity to undergo urothelial engraftment
has not been observed. MSC have been reported to progress
toward a urothelial lineage in vitro under selective culture
conditions [24,25], however these cell types may be restricted in
their in vivo potential to differentiate into mature urothelium.
These studies highlight the need to evaluate other cell sources for
bladder tissue repair.
Pluripotent populations such as embryonic stem cells (ESC) and
induced pluripotent stem (iPS) cells may fulfill the need for
alternative cell sources for bladder regeneration. ESC are derived
from the inner cell mass of blastocysts and have the potential for
the production of patient-specific tissues either through stem cell
banking or via somatic cell nuclear transfer [26]. iPS cells are
reprogrammed, terminally differentiated somatic cells which have
acquired ESC-like properties following ectopic expression of
various pluripotency transcription factors [27,28]. Unlike MSC
which undergo senescence following prolonged ex vivo cultivation
[29], these cell lines can be theoretically expanded for indefinite
periods [27,30], thus providing large amounts of cells for tissue
repair. In comparison to multi-potent MSC, the pluripotent nature
of ESC and iPS cells also endows them with the capacity to
differentiate into a greater assortment of potential lineages for the
creation of tissue engineered constructs [31]. In addition, we have
previously reported the ability of murine ESC to undergo both
SMC and urothelial differentiation in vitro [32], while iPS cells
have been shown to acquire features of contractile SMC [33].
Development of strategies which can deliver these pluripotent cell
lines into defect sites as well as promote their lineage-specific
differentiation is desired to generate functional bladder tissue and
avoid unwanted teratoma formation.
Biomaterial configurations possessing microenviromental fea-
tures appropriate to enable attachment, proliferation, and
differentiation of both primary and pluripotent cells have the
advantage of providing clinicians flexibility in using available cell
sources with a common scaffold template for bladder tissue
engineering. Therefore, the goal in the present study was to assess
the potential of gel spun silk scaffolds to support these processes in
primary SMC and urothelial cell lines as well as ESC and iPS cells.
In addition, since previous investigations have demonstrated that
functionalization of silk biomaterials with tissue-specific extracel-
lular matrix (ECM) proteins and motifs enhances their overall
biocompatibility [34,35], we also determined the effect of different
ECM protein coatings on the ability of silk matrices to support cell
responses in parallel.
Materials and Methods
Ethics Statement
Bombyx mori silkworm cocoons were obtained from a
commercial supplier (Tajima Shoji Co., Yokohama, Japan) and
therefore no specific field studies were performed for their
acquisition.
Biomaterials
Aqueous silk fibroin solutions were prepared from Bombyx mori
silkworm cocoons using previously described procedures [12]. Silk
matrices were formed using a published gel spinning technique
[15]. Tubular scaffolds were produced by spinning concentrated
silk solutions [25–30% (w/v), 0.5 ml/scaffold] onto a rotating
(200 rpm) and axially reciprocating mandrel (6 mm in diameter)
using a custom gel spinning platform and program. Two groups of
matrices previously shown to support murine bladder augmenta-
tion, but with different structural and mechanical properties, were
generated with various winding and post-winding conditions
[16,17]. Group 1 scaffolds were spun with an axial slew rate (ASR)
of 2 mm/sec followed by treatment with methanol. Group 2
scaffolds were composed of ,0.4 ml of silk solution spun at an
ASR of 40 mm/sec followed by ,0.1 ml spun at 2 mm/sec in
order to consolidate gaps between the resultant silk fibers. This
matrix group was then subjected to lyophilization and subsequent
methanol treatment. The tubes were then removed from the
mandrel after briefly soaking in a surfactant solution. Matrices
were bisected along their central axis, cut into individual squares
(565m m
2), sterilized in 70% ethanol, and rinsed in phosphate
buffered saline (PBS) overnight. To facilitate ECM protein
coatings, collagen type I (from rat tail, cat.# 1179179, Roche
Applied Science, Indianapolis, IN), collagen type IV (from human
placenta, cat.# C7521, Sigma Aldrich, St. Louis, MO), and
fibronectin (from bovine plasma, cat.# F4759, Sigma Aldrich)
were prepared as sterile aqueous solutions (0.1 mg/ml) and
independently incubated with silk scaffolds for 1 h at 37uC
followed by 1 h of drying in a laminar flow hood at room
temperature. Uncoated controls were prepared in parallel with
incubation in PBS.
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Structural analysis of uncoated matrix groups was performed in
order to assess differences in scaffold morphology. Matrix samples
were sputter coated with gold and imaged using a Hitachi S-520
Scanning Electron Microscope (Hitachi, Tokyo, Japan).
Bladder Smooth Muscle Cells
Human primary SMC, isolated from the urinary bladder
(passage 3), were obtained commercially (Lonza, Walkersville,
MD) and expanded for 3 additional passages on 185 cm
2 tissue
culture plates in Smooth Muscle Growth Medium-2 (SmGM-2,
Lonza) according to the manufacturer’s instructions. SmGM-2
consists of a proprietary Smooth Muscle Basal Medium (SmBM)
containing 5% fetal calf serum (FCS), epidermal growth factor
(EGF), insulin, basic fibroblast growth factor (bFGF), and
gentamicin/amphotericin-B. For cell attachment and proliferation
analyses, SMC (passage 6) were seeded on uncoated or ECM-
coated matrices (10
6 cells/scaffold) in SmGM-2 and cultured for
up to 7 d. Medium exchange was carried out every 3 d. To induce
contractile differentiation, SMC were seeded on matrices as
described above, serum depleted for 24 h in SmBM containing
0.5% FCS, and subsequently exposed to 2.5 ng/ml TGFb-1
(R&D Systems, Minneapolis, MN) for 24 h. Control cultures were
maintained in parallel in SmGM-2 for 3 d.
Urothelial Cells
A previously described non-transformed human urothelial cell
line, TRT-HU1, derived from cadaveric bladder biopsies [36] was
expanded to passage 13 on 185 cm
2 tissue culture plates in basal
medium consisting of Dulbecco’s modified Eagle’s medium
(DMEM, Invitrogen, Carlsbad, CA) supplemented with 15%
FCS (Invitrogen), 2 mM L-glutamine (Invitrogen), 100 units/ml
penicillin (Invitrogen), 100 mg/ml streptomycin (Invitrogen),
0.1 mM nonessential amino acids (Invitrogen), and 1 mM 1-
thioglycerol (Sigma Aldrich). Urothelial cells were seeded on
uncoated or ECM-coated matrices (10
6 cells/scaffold) and
cultured in basal medium for up to 9 d to assess cell attachment,
extent of proliferation, and differentiation status. Medium
exchange was performed every 3 d.
Embryonic and Induced Pluripotent Stem Cells
Murine ESC (C57BL/6 line, American Type Culture Collec-
tion, Manassas, VA) and iPS cells (T1b line, Stemgent, Cam-
bridge, MA) were expanded on c-irradiated murine embryonic
fibroblasts (MEF) in DMEM supplemented with 15% FCS, 100
units/ml penicillin, 100 mg/ml streptomycin, 0.1 mM nonessential
amino acids, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol
(Millipore, Billerica, MA), and 10
3 units/ml leukemia inhibitory
factor (LIF, Millipore). Following expansion, pluripotency marker
(OCT4) expression was assessed by immunocytochemical (ICC)
analysis. Briefly, cultures were fixed with 10% neutral-buffered
formalin and OCT4 expression was detected following incubation
with primary antibody (anti-OCT4, Cell Signaling Technology,
Danvers, MA, cat.# 2840, 1:200 dilution) and species-matched
Cy3-conjugated secondary antibody (Millipore). Nuclei were
counterstained with 49, 6-diamidino-2-phenyllindole (DAPI) and
cultures were visualized as described below. To induce in vitro
differentiation of bladder cell phenotypes, feeder-depleted ESC
and iPS cells were seeded on uncoated or ECM-coated silk
scaffolds (10
6 cells/scaffold) in basal medium supplemented with
all trans retinoic acid (RA, Sigma-Aldrich) [10 mM] and cultured
for up to 14 d with daily medium changes as previously described
[32]. Spontaneously differentiating controls in the absence of RA
were maintained in parallel.
Cell Attachment and Proliferation Analyses
The relative number of metabolically active cells following 24 h
of cell seeding and over the course of cultivation on uncoated and
ECM-coated silk matrices was determined by the alamarBlue
assay (Invitrogen) according to the manufacturer’s instructions.
Briefly, scaffolds seeded with primary and pluripotent cell lines
were incubated in their respective culture medium supplemented
with 10% alamarBlue reagent for 2 h at 37uC with 5% CO2. Post
reaction medium aliquots (100 ml) were transferred to 96 well
plates and quantified for fluorescence intensity within a FLUOstar
Omega plate reader (BMG Labtech Inc., Durham, NC) using an
excitation wavelength of 560 nm and an emission wavelength of
590 nm. Non-seeded matrices were screened in parallel as
background controls. Relative cell numbers were calculated as
the degree of relative fluorescence units (FU) per construct.
mRNA Analyses
Total RNA was extracted from seeded scaffolds according to the
single step acid-phenol guanidinium method [37] using Trizol
reagent (Invitrogen). mRNA was enriched from total RNA using
the RNeasy kit (Qiagen Inc., Valencia, CA) and cDNAs were
Figure 1. Structural morphology of silk scaffold groups and characterization of ECM coatings. SEM photomicrographs of cross-sectional
and top views (inset) of silk scaffold configurations. Scale bars = 300 mm; inset, scale bars = 200 mm. Photomicrographs of H&E-stained cross-
sections of unseeded scaffold groups and immunofluorescence of various ECM coatings (collagen types I or IV or fibronectin) on matrices prior to cell
seeding with similar orientation (Cy3 fluorophore, red). Scale bars = 100 mm. SC denotes scaffolds. Arrows denote intercalation of ECM coatings
within scaffold pores.
doi:10.1371/journal.pone.0056237.g001
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(Applied Biosystems, Foster City, CA) following the manufactur-
er’s instructions. Real time RT-PCR reactions were performed
and analyzed using the Applied Biosystems StepOnePlus
TM Real
time PCR Detection System and StepOne Software (version 2.1).
cDNA samples were assessed for genes of interest and the
housekeeping gene, GAPDH, in independent reactions using the
Taqman Universal PCR master mix in combination with
commercially available primers and probes consisting of Assays-
on-Demand
TM Gene Expression kits (Applied Biosystems) follow-
ing the manufacturer’s instructions. Expression kits included:
murine: uroplakin (UP) 1A, Mm01176597_g1; UP1B,
Figure 2. Silk biomaterial structure and specific ECM coatings influence SMC attachment and contractile differentiation. [A]
AlamarBlue analysis of the extent of relative SMC attachment and proliferation on uncoated or ECM-coated (collagen types I or IV or fibronectin) silk
groups following 1 and 7 d of culture, respectively. FU= Fluorescent units, mean 6 SD per data point. (*) = p#0.05, in comparison to levels
observed on uncoated Group 2 controls at 1 d. [B] Photomicrographs of SMC-seeded constructs (H&E-stained sections) following 7 d of culture as
described in [A]. Scale bars = 100 mm; magnified inset, scale bars = 50 mm. [C, D] Real time RT-PCR analyses of mRNA transcript levels of contractile
protein genes (a-actin [C] and SM22a [D]) in synthetic (SYN) and TGFb1-treated constructs described in [A]. Levels normalized to GAPDH expression.
Mean 6 SD per data point. For each marker, (*) = p#0.05, in comparison to levels in respective SYN controls. [E, F] Photomicrographs of contractile
protein (a-actin [C] and SM22a [D]) expression in TGFb1-treated constructs described in [C]. Immunofluorescence of contractile proteins (Cy3
fluorophore, red). DAPI nuclear counterstain (blue). Scale bars = 100 mm; magnified inset, scale bars = 50 mm. For [B, E, F], SC denotes scaffolds.
doi:10.1371/journal.pone.0056237.g002
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Mm00447665_m1, GAPDH, Mm99999915_g1; OCT4,
Mm00658129_gH; Nanog, Mm02019550_s1; REX1,
Mm01194090_g1; a-actin, Mm00725412_s1; smooth muscle
myosin heavy chain (SM-MHC), Mm00443013_m1; SM22a,
Mm00441660_m1; human: a-actin, Hs00426835_g1; SM22a,
Hs00162558_m1; GAPDH, Hs99999905_m1. For each cDNA
sample, the threshold cycle (Ct) was defined as the cycle number at
which amplification of the target gene was within the linear range
of the reaction. Relative expression levels for each gene of interest
were calculated by normalizing the target gene transcript level (Ct)
to the respective GAPDH level with the maximum expression
values per gene displayed at a 100 per condition as described
previously [32].
Histological and Immunohistochemical (IHC) Analyses
Non-seeded and seeded constructs were fixed in 10% neutral-
buffered formalin, dehydrated in graded alcohols, and embedded
in paraffin. For detection of fibronectin coatings, scaffolds were
placed in OCT compound and frozen at -80uC. Serial sections
(10 mm) were cut from paraffin and OCT blocks and either stained
with hematoxylin and eosin (H&E) or subjected to IHC analyses.
To verify ECM protein coatings on non-seeded scaffolds, the
following primary antibodies were used: anti-collagen type I
(Abcam, Cambridge, MA, cat.# ab34710, 1:200 dilution), anti-
collagen type IV (Abcam, cat.# ab6586, 1:200 dilution), and anti-
fibronectin (Millipore, cat.# AB2047, 1:200 dilution). For
differentiation analyses, contractile smooth muscle markers such
as a-actin and SM22a [38] as well as urothelial-associated
proteins, uroplakins (UP) [39] and cytokeratins (CK) [40], were
detected using the following primary antibodies: anti-a-actin
(Sigma-Aldrich, cat.# A2457, 1:200 dilution), anti-SM22a
(Abcam, Cambridge, MA, cat.# ab14106, 1:200 dilution), anti-
pan-UP (rabbit antisera raised against total bovine UP extracts,
1:100 dilution), anti-pan-CK (Dako, Carpinteria, CA, cat.#
M3515, 1:200 dilution). Specimens were incubated with respective
species-matched Cy3-conjugated secondary antibodies (Millipore)
to ascertain primary antibody localization. Nuclei were counter-
stained with DAPI and sections were visualized using an Axioplan-
2 microscope (Carl Zeiss MicroImaging, Thornwood, NY) and
representative images were acquired using Axiovision software
(version 4.8, Thornwood, NY).
Statistical Analyses
All quantitative measurements were collected with N=3–4
independent replicates per data point from one representative
experiment and expressed as mean 6 standard deviation. Data for
these measurements were analyzed with the Mann-Whitney U test
using SPSS Statistics software v19.0 (http://www.spss.com).
Statistically significant values were defined as p#0.05.
Results and Discussion
We investigated two groups of silk scaffold configurations as
potential templates for the development of cell-seeded constructs
for bladder tissue engineering. These matrices were chosen based
on their reported ability to support bladder augmentation as well
as smooth muscle and urothelial regeneration in normal rodents
[16,17]. SEM analysis (Figure 1) demonstrated that Group 1
scaffolds consisted of compact multi-laminates of parallel-oriented
silk fibers whose architecture was preserved following post-winding
methanol treatment. In contrast, we observed that Group 2
scaffolds were composed of porous lamellar-like sheets buttressed
by a dense outer layer, devoid of initial winding patterns, but with
increased surface roughness compared to Group 1 (Figure 1).
Comparisons between these structurally diverse scaffold groups
allowed for an interrogation of how silk biomaterial morphology
affects primary and pluripotent cell responses.
To more accurately mimic the natural tissue microenvironment,
scaffolds in both groups were incubated with bladder-associated
ECM components such as collagen types I or IV or fibronectin
prior to cell seeding. In the normal bladder wall, collagen type I is
primarily expressed in the lamina propria wherein it surrounds
smooth muscle bundles and nerves [41]. The urothelium is
supported by the basement membrane which is predominantly
composed of a network of collagen type IV and laminin [41].
Fibronectin is a non-collagenous glycoprotein associated with
superficial urothelial cells which also encompasses individual
smooth muscle fibers and vessel walls within the lamina propria
[41]. For each ECM investigated, IHC analyses demonstrated the
formation of qualitatively similar degrees of protein coatings
localized around the periphery of each scaffold group (Figure 1).
In addition, Group 2 matrices also displayed intercalation of all
ECM coatings within their internal porous network to similar
degrees
Uncoated and ECM-coated scaffold groups were assessed for
their ability to support SMC attachment and proliferation
(Figure 2A, B). Following 24 h of cell seeding, alamarBlue
analysis demonstrated that uncoated Group 2 scaffolds supported
elevated levels of relative cell attachment in comparison to
uncoated Group 1 matrices. However, augmentation of Group 2
scaffolds with collagen type I or fibronectin significantly increased
values over uncoated controls with the latter leading to the highest
degree of cell attachment observed among any of the experimental
groups at this timepoint. In contrast, ECM coatings had a
negligible effect on the propensity of Group 1 scaffolds to support
this parameter. Following 7 d of culture, no significant differences
in relative cell numbers over day 1 levels were observed in any of
the groups suggesting minimal cell proliferation. Histological
comparisons of uncoated and fibronectin-coated groups at 7 d
demonstrated that SMC were typically localized in patches of
multi-cellular layers dispersed around the periphery of each
scaffold group (Figure 2B), despite the increased surface area
present within the porous network of Group 2 scaffolds. These
results suggest that elevated alamarBlue levels seen in SMC
cultured on Group 2 matrices in comparison to Group 1 may be a
consequence of differences in other structural features between the
groups. One probable candidate is the increased level of surface
roughness encountered on Group 2 scaffolds. Indeed, a previous
study of vascular SMC responses to metallic stents showed a
positive correlation between the extent of cell adhesion and the
degree of surface roughness [42]. These data collectively show that
the structural architecture of Group 2 scaffolds coupled with
fibronectin coatings produced a superior substrate for promoting
SMC attachment in comparison to other scaffold formulations
tested.
Following tissue isolation and ex vivo expansion, SMC derived
from both vascular and visceral organs dedifferentiate from a
quiescent contractile phenotype into a proliferative, synthetic state
[43,44]. In order for tissue engineered constructs to reconstitute
the contractile properties of bladder defects, biomaterial config-
urations must support contractile differentiation of ex vivo
expanded, synthetic SMC. Previous studies have demonstrated
the ability of serum deprivation in combination with TGF-b1
treatment to stimulate contractile differentiation of ureteral SMC
[43]. Therefore, we investigated the potential of these differenti-
ation stimuli to elicit similar responses in bladder SMC cultured on
uncoated and fibronectin-coated silk scaffolds. Real time RT-PCR
Bladder Tissue Engineering
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marker expression including a-actin and SM22a in TGFb1-
treated SMC cultured on all matrices examined (Figure 2C, D).
However, fibronectin-coated constructs in each group displayed
the highest degree of expression of both contractile genes in
comparison to their uncoated counterparts. IHC analyses revealed
similar degrees of a-actin and SM22a protein expression in
TGFb1-treated SMC cultured on both fibronectin-coated groups
(Figure 2E, F). In addition, cells stimulated on uncoated Group 2
scaffolds exhibited comparable levels of a-actin and SM22a
expression in respect to fibronectin-coated constructs; however
SMC cultured on uncoated Group 1 scaffolds displayed weak and
sparse expression of both markers. Overall these results demon-
strate that silk groups modified with fibronectin coatings are
efficacious in supporting SMC contractile differentiation.
The bladder and associated urinary tract are lined by the
urothelium, a transitional epithelium which acts as a specialized
permeability barrier that protects the underlying tissue from toxic
urinary components [39]. The ability of tissue-engineered
constructs to reconstitute the barrier function of bladder defects
depends on the potential of scaffold configurations to support
urothelial integration and differentiation. Uncoated and ECM-
coated silk matrices were evaluated for their capacity to promote
urothelial cell attachment and proliferation (Figure 3A, B).
AlamarBlue analysis revealed that following initial cell seeding,
uncoated Group 2 scaffolds supported substantially higher degrees
of relative cell attachment in comparison to uncoated Group 1
matrices. In addition, fibronectin coating of Group 2 scaffolds
further increased the extent of cell attachment to levels higher than
observed with any other ECM coating. However, relative
urothelial cell attachment to Group 1 matrices was minimally
effected by the presence of any of the ECM coatings tested.
Over the course of 7 d of cultivation, relative cell numbers
significantly increased on uncoated and collagen I-coated Group 1
matrices in comparison to day 1 levels. In contrast, minimal
urothelial cell proliferation occurred on uncoated or ECM-coated
Group 2 scaffolds. However, fibronectin-coated Group 2 matrices
maintained the highest level of relative urothelial cell numbers in
comparison to all other experimental conditions tested at 7 d.
Histological comparisons of uncoated and fibronectin-coated
groups at this timepoint demonstrated dispersed regions of
multi-cellular layers of urothelial cells primarily lining the
periphery of all scaffold configurations. Similar to the responses
seen in SMC, the overall higher degrees of cellularity observed in
Figure 3. Urothelial cell attachment and proliferation are modulated by silk biomaterial morphology and selective ECM coatings.
[A] AlamarBlue analysis of the extent of relative urothelial cell attachment and proliferation on uncoated or ECM-coated (collagen types I or IV or
fibronectin) silk groups following 1 and 7 d of culture, respectively. FU= Fluorescent units, mean 6 SD per data point. (*) = p#0.05, in comparison
to levels observed on respective 1 d counterparts. [B] Photomicrographs of urothelial cell-seeded constructs (H&E-stained sections) following 7 d as
described in [A]. Scale bar = 100 mm; inset, scale bar = 50 mm. [C] Photomicrographs of pan-cytokeratin protein expression in urothelial cells
cultured for 9 d on control and fibronectin-coated groups. Immunofluorescence of pan-cytokeratins (Cy3 fluorophore, red). DAPI nuclear
counterstain (blue). Scale bars = 100 mm; magnified inset, scale bars = 50 mm. For [B,C], SC denotes scaffolds.
doi:10.1371/journal.pone.0056237.g003
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due to increased surface roughness encountered on this matrix
configuration. A study by Chun and colleagues provided evidence
for this notion showing increased urothelial cell adhesion to poly-
lactic-co-glycolic acid and poly-(ether)-urethane polymers follow-
ing enhancement of surface roughness by chemical etching [45].
IHC analyses confirmed the ability of uncoated and fibronectin-
coated scaffold groups to support expression of differentiation-
associated markers such as cytokeratins in seeded urothelial cells
by demonstrating prominent protein staining following 9 d of
culture (Figure 3C). Overall, these findings show that fibronectin-
coated Group 2 scaffolds provide an optimal scaffold for urothelial
cell responses in comparison to other matrix configurations by
promoting the highest degree of construct cellularity while
supporting a differentiated phenotype.
ESC and iPS cells were investigated for their potential to
function as cell sources for bladder tissue engineering. Phase
contrast microscopy and ICC analyses of ESC and iPS cell lines
revealed similar morphological features including the formation of
refractile, multi-cellular colonies during ex vivo expansion which
exhibited prominent nuclear expression of the pluripotency
marker, OCT4, in contrast to MEF feeder layers (Figure 4A).
The ability of uncoated and ECM-coated scaffolds to support ESC
and iPS cell attachment was determined by AlamarBlue analysis
(Figures 4B, C). For each respective cell line, similar degrees of
relative cell attachment were observed between Group 1 and 2
scaffolds either uncoated or coated with collagen types I or IV. In
contrast, fibronectin coatings significantly increased the degree of
ESC attachment on both types of matrix configurations in respect
to uncoated controls with Group 2 matrices displaying the highest
levels over all conditions. Fibronectin coatings did not affect the
propensity of Group 1 scaffolds to promote iPS cell attachment
over control levels; however this ECM coating did significantly
elevate the extent of cell attachment over uncoated matrices.
These data demonstrate that the combination of matrix architec-
ture and the presence of fibronectin coatings play a major role in
influencing the extent of pluripotent cell attachment.
RA is known to function in both a time- and concentration-
dependent manner to selectively regulate the specification of ESC
and iPS cells into various types of differentiated lineages
[38,46,47]. In particular, our previous study demonstrated the
ability of continuous stimulation of ESC with micromolar
concentrations of RA to promote both urothelial and SMC
differentiation in monolayer cultures as well as neuronal and extra-
embryonic cell types [32]. Although RA stimulation has been
reported to induce SMC differentiation in iPS cells [33], its ability
to stimulate urothelial differentiation is unknown. Therefore, we
hypothesized that fibronectin-coated Group 2 matrices would
function as biocompatible substrates to support RA-mediated
differentiation of both ESC and iPS cells toward SMC and
urothelial lineages. Over the course of the 14 d culture period, real
time RT-PCR analyses demonstrated that in response to RA, ESC
(Figure 5A) and iPS cells (Figure 5B) elicited significant
downregulation of all pluripotency factor mRNA transcript levels
tested in comparison to naı ¨ve controls. In addition, RA stimulation
promoted significant induction of all urothelial-associated uropla-
Figure 4. Group 2 silk scaffold architecture coupled with fibronectin coatings maximizes pluripotent stem cell attachment. [A]
Photomicrographs of phase contrast images of naı ¨ve ESC and iPS cells prior to scaffold seeding. Immunofluorescence of the pluripotent marker,
OCT4, in ESC and iPS cells (Cy3 fluorophore, red). DAPI nuclear counterstain (blue). Scale bars for phase and immunofluorescence images = 100 mm.
[B, C] AlamarBlue analysis of the extent of relative ESC [B] and iPS cell [C] attachment on uncoated or ECM-coated (collagen types I or IV or
fibronectin) silk groups following 1 d of culture. FU= Fluorescent units, mean 6 SD per data point. (*) = p#0.05, in comparison to levels observed
on respective uncoated controls.
doi:10.1371/journal.pone.0056237.g004
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tested in comparison to undifferentiated and spontaneously
differentiating controls. Parallel IHC analyses of RA-treated
constructs seeded with ESC (Figure 6A) and iPS cells
(Figure 6B) demonstrated the formation of distinct cell popula-
tions with fibroblastic morphology displaying prominent contrac-
tile protein expression, including a-actin and SM22a, indicative of
SMC differentiation. In addition, cytokeratin-positive cells with
cuboidal epithelial-like morphology were also detected in both
seeded cell populations in response to RA. Urothelial maturation
of RA-treated ESC was evident in epithelial subpopulations which
exhibited uroplakin protein expression. In contrast, uroplakin-
positive cells were not detected in iPS cell-seeded constructs
cultured under similar conditions. These results provide evidence
that silk scaffolds are permissive for SMC and urothelial
differentiation of pluripotent cell lines. However, ESC may be a
more optimal cell source for bladder tissue engineering given the
Figure 5. RA stimulates SMC and urothelial markers in pluripotent stem cells cultured on silk scaffolds. [A, B] Real time RT-PCR analyses
of mRNA transcript levels of pluripotency transcription factors (OCT4, Nanog, REX1), SMC contractile genes (SM-MHC, a-actin, SM22a), and urothelial-
associated uroplakins (UP) in ESC [A] or iPS cells [B] cultured on fibronectin-coated Group 2 matrices for 14 d in the presence of RA or maintained as
spontaneously differentiating controls (C). D0 = naı ¨ve, undifferentiated controls. Levels normalized to GAPDH expression. Mean 6 SD per data point.
(#)=p#0.05, in comparison to D0. (*) = p#0.05, in comparison to D0 and C conditions.
doi:10.1371/journal.pone.0056237.g005
Figure 6. SMC and urothelial populations in RA-treated pluripotent stem cells cultured on silk scaffolds. [A, B] Photomicrographs of
SMC contractile protein expression (a-actin and SM22a) and urothelial-associated markers [pan-cytokeratins (CK) and pan-uroplakins (UP)] in ESC [A]
and iPS cells [B] cultured on fibronectin-coated Group 2 matrices for 14 d in the presence of RA. (Cy3 fluorophore, red). DAPI nuclear counterstain
(blue). Scale bars = 100 mm; magnified inset, scale bars = 50 mm. SC denotes scaffolds in all panels.
doi:10.1371/journal.pone.0056237.g006
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iPS cells.
Conclusion
Structural morphology and the presence of specific ECM
coatings were found to be significant factors in influencing the
performance of silk biomaterials to support primary and plurip-
otent cell attachment and differentiation. In comparison to other
scaffold formulations evaluated in this study, the combination of
fibronectin coatings with Group 2 scaffold architecture promoted
the highest level of primary SMC and urothelial cell attachment as
well as supported their respective differentiated phenotypes. In
addition, this matrix was also superior in mediating ESC and iPS
cell attachment and upon treatment with RA, SMC and urothelial
differentiation could be achieved. Previous reports have demon-
strated the ability of conventional scaffolds such as PGA and SIS
to support primary SMC and urothelial attachment and differen-
tiation [4,7], however fibronectin-coated Group 2 silk matrices
offer the additional advantage of supporting maturation of
pluripotent cell types into bladder-associated lineages which may
be useful in bladder reconstruction strategies when primary cell
function is compromised due to disease. In summary, fibronectin-
coated Group 2 scaffolds consisting of rough, porous lamellar-like
sheets of gel spun silk fibroin represent promising platforms for
cell-seeded bladder tissue engineering approaches.
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